Patents by Inventor MICHAEL WIESSNER

MICHAEL WIESSNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250095947
    Abstract: A rotary piston X-ray source including a housing, a rotary piston X-ray source, and a magnetic deflection unit. The rotary piston X-ray source is mounted inside the housing to be rotatable about an axis of rotation relative to the housing. The magnetic deflection unit includes at least one multipole and is disposed outside the rotary piston. The at least one multipole has at least four magnetic poles, which are disposed about the axis of rotation and include coil windings. The magnetic poles further define a multipole plane on which a central axis of the at least one multipole is perpendicularly centered, and the at least one multipole is arranged such that the central axis of the at least one multipole and the axis of rotation span a surface.
    Type: Application
    Filed: September 18, 2024
    Publication date: March 20, 2025
    Applicant: Siemens Healthineers AG
    Inventors: Florian HOLCH, Michael WIESSNER, Florian SEPERANT, Dieter MATUSZOK, Peter ROEHRER
  • Publication number: 20240303803
    Abstract: One or more example embodiments of the present invention relates to a computer-implemented method for assessing a component quality of an electron emitter as a function of an ascertained degree of similarity with at least one further electron emitter.
    Type: Application
    Filed: March 6, 2024
    Publication date: September 12, 2024
    Applicant: Siemens Healthineers AG
    Inventors: Malte TSCHENTSCHER, Andreas SELMAIER, Brian DA SILVA TEIXEIRA, Ankur KAPOOR, Vivek SINGH, Florian HOLCH, Patrick LUEHRING, Michael WIESSNER
  • Publication number: 20230288402
    Abstract: The present invention relates to a method for identifying a pharmaceutically active compound that modulates the rpL35 (rpL35/rpL29)-dependent translation of at least one mRNA in a mammalian cell. The mRNA may comprise a premature termination codon (PTC), undergoes premature translation termination, causes programmed ?1 ribosomal frame shifting (?1PRF), or is a polycistronic mRNA. Furthermore a respective screening system, methods of treating or preventing a disease or condition, and compounds that modulate the rpL35 (rpL35/rpL29)-dependent translation, in particular atazanavir or derivatives thereof and artemisinin or artesunate or derivatives thereof are provided.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 14, 2023
    Inventors: HANNELORE BREITENBACH-KOLLER, JÖRG VON HAGEN, HELMUT HINTNER, FRIEDRICH LOTTSPEICH, HANS-WERNER MEWES, NORBERT MÜLLER, ANDREAS FRIEDRICH, KATHARINA ELSENSOHN, CLAUDIA MOSSHAMMER, MICHAEL WIESSNER, THOMAS KARL, JAN SCHERNTHANER, ADRIANA RATHNER